Connection

Pål Aukrust to Receptors, Chemokine

Back to Details
This is a "connection" page, showing publications Pål Aukrust has written about Receptors, Chemokine.
Pål Aukrust
Connection Strength
0.183
Receptors, Chemokine
  1. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. Front Immunol. 2018; 9:2035.
    View in: PubMed
    Score: 0.183
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.